(Q42905530)

English

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009)

scientific article published on September 16, 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008–2009) (English)

reason for preferred rank

most precise value

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846808

14 July 2024

antimicrobial resistance

1 reference

based on heuristic

inferred from title

Michael A. Pfaller

1

object named as

Michael A Pfaller

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Mariana Castanheira

2

object named as

Mariana Castanheira

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

3

object named as

Shawn A Messer

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

5

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

author name string

Gary J. Moet

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20846808

14 July 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846808

14 July 2024

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0732889310002476?httpAccept=text/xml

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

https://api.elsevier.com/content/article/PII:S0732889310002476?httpAccept=text/plain

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

68

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

278-283

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole

2

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

3

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.

4

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment

5

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies

9

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage

10

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

11

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy

12

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Fungal infections in older adults

13

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

14

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Treatment-related risk factors for hospital mortality in Candida bloodstream infections

15

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candida glabrata fungemia: experience in a tertiary care center

16

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

17

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Caspofungin for the treatment of candidaemia in patients with haematological malignancies.

18

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains

19

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

20

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

21

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Epidemiology of invasive candidiasis: a persistent public health problem

22

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Epidemiology of invasive mycoses in North America

23

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

24

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

25

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.

26

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods

27

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp.

28

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.

30

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Breakthrough invasive candidiasis in patients on micafungin

31

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Echinocandin pharmacodynamics: review and clinical implications.

32

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candidemia in Norway (1991 to 2003): results from a nationwide study

33

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links

34

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection

35

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death

36

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

37

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

38

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Setting and revising antibacterial susceptibility breakpoints

39

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

40

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Secular trends in candidemia-related hospitalization in the United States, 2000-2005

41

1 reference

10.1016/J.DIAGMICROBIO.2010.06.015

https://api.crossref.org/works/10.1016/J.DIAGMICROBIO.2010.06.015

14 July 2024

Identifiers

10.1016/J.DIAGMICROBIO.2010.06.015

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42905530&oldid=2204293776"